XML 63 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Common Stock Incentive Plan (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of nonvested restricted stock activity
The following table summarizes our common stock grant activity:
 202220212020
Number of shares
Weighted average price(1)
Number of shares
Weighted average price(1)
Number of shares
Weighted average price(1)
Outstanding nonvested shares, beginning of year
212,630 $65.20 219,482 $63.69 259,698 $58.39 
Shares granted(2) 
156,274 $67.37 133,052 $64.27 103,473 $67.84 
Shares vested(118,160)$63.95 (124,505)$61.57 (141,486)$56.94 
Shares forfeited(8,084)$67.78 (15,399)$65.09 (2,203)$66.48 
Outstanding nonvested shares, end of each period
242,660 $67.12 212,630 $65.20 219,482 $63.69 
(1)  Grant date fair value.
(2) Our restricted stock awards granted to employees vest over a service periods not exceeding four-years. Effective November 1, 2022, and applied retroactively for all outstanding awards, restricted stock awards granted to employees with 10 years of continued service and 60 years of age will vest over the shorter of the original vesting term or the period through the date in which the awardee reaches age 60.
Schedule of number of performance shares that vest based on the achievement of performance goals The number of performance shares that vest for each of the three years is based on the achievement of the following performance goals:
Weighting for year granted
Annual Performance Awards Metrics202220212020
Total shareholder return (“TSR”) ranking relative to MSCI US REIT Index55 %70 %70 %
Dividend per share growth rate20 %15 %15 %
Net Debt-to-Pro Forma Adjusted EBITDAre Ratio
25 %N/AN/A
Net Debt-to-Adjusted EBITDAre Ratio
N/A15 %15 %
Schedule of nonvested performance shares activity The following table summarizes our performance share grant activity, inclusive of annual performance shares and the one-time performance shares related to the merger with VEREIT:
202220212020
Number of performance shares
Weighted average price(1)
Number of performance shares
Weighted average price(1)
Number of performance shares
Weighted average price(1)
Outstanding nonvested shares, beginning of year
388,139 $68.09 291,759 $69.73 304,663 $62.25 
Equitable adjustment - Orion Divestiture (2)
— 752 — 
Shares granted174,940 $77.73 257,149 $64.18 136,729 $79.98 
Shares vested(74,247)$59.62 (109,113)$62.52 (139,012)$63.66 
Shares forfeited(17,952)$58.59 (52,408)$65.83 (10,621)$66.64 
Outstanding nonvested shares, end of each period
470,880 $73.37 388,139 $68.09 291,759 $69.73 
(1) Grant date fair value.
(2) Effective with the Orion Divestiture on November 12, 2021, outstanding equity awards were adjusted by a conversion ratio of 1.002342 per one Realty Income share then held.
Schedule of nonvested restricted stock units activity
During 2022, 2021 and 2020, and in connection with our merger with VEREIT Inc., we also granted restricted stock units that primarily vest over service periods of three or four-years and have the same economic rights as shares of restricted stock: 
 202220212020
Number of restricted stock units
Weighted average price(1)
Number of restricted stock units
Weighted average price(1)
Number of restricted stock units
Weighted average price(1)
Outstanding nonvested shares, beginning of year
67,367 $69.69 18,670 $70.38 15,511 $59.82 
Equitable adjustment - Orion Divestiture (2)
— 109 — 
Shares granted 24,820 $66.82 71,956 $68.96 9,966 $78.79 
Shares vested(26,917)$70.55 (23,368)$66.96 (6,807)$58.63 
Shares forfeited(6,757)$71.14 — — 
Outstanding nonvested shares, end of each period
58,513 $67.91 67,367 $69.69 18,670 $70.38 
(1) Grant date fair value.
(2) Effective with the Orion Divestiture on November 12, 2021, outstanding equity awards were adjusted by a conversion ratio of 1.002342 per one Realty Income share then held.
Schedule of stock option activity
The following table summarizes our stock option activity during the year ended December 31, 2022: 
Number of stock options
Weighted average exercise price (1)
Weighted average remaining contractual term (Years)Aggregate intrinsic value
Outstanding nonvested options, beginning of year315,070 $52.89 
Options exercised(262,267)$52.41 
Options forfeited(7,424)$58.46 
Outstanding nonvested options, end of each period45,379 $54.75 5.8$393,710 
(1)Grant date fair value.
The following table summarizes our stock option activity during the year ended December 31, 2021: 
Number of stock options
Weighted average exercise price(1)
Weighted average remaining contractual term (Years)Aggregate intrinsic value
Outstanding nonvested options, beginning of year— 
Options granted (2)
709,426 $53.80 
Equitable adjustment - Orion Divestiture (3)
1,547 
Options exercised(395,903)$54.54 
Options forfeited— 
Outstanding nonvested options, end of each period315,070 $52.89 2.4$5,891,639 
(1) Grant date fair value.
(2) During the year ended December 31, 2021, stock options were granted in connection with the VEREIT merger.
(3) Effective with the Orion Divestiture on November 12, 2021, outstanding equity awards were adjusted by a conversion ratio of 1.002342 per one Realty Income share then held.